Bacterial And Viral Specimen Collection Market Report 2026

Bacterial And Viral Specimen Collection Market Overview

• Bacterial And Viral Specimen Collection market size has reached to $23.86 billion in 2025 • Expected to grow to $44.98 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Urbanization And Disease Transmission • Market Trend: Innovative Viral DNA/RNA Extraction Kits Drive Advances In Pathogen Detection And Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bacterial And Viral Specimen Collection Market?

Bacterial and viral specimen collection refers to the careful process of obtaining biological samples, such as swabs from the nose or throat, body fluids, or tissue samples, to detect, identify, and study bacterial or viral pathogens responsible for infections. This process requires the use of sterile equipment, correct collection techniques, and proper storage or transport methods to ensure the microorganisms remain intact and viable for accurate laboratory analysis. The main product types of the bacterial and viral specimen collection include bacterial specimen collection and viral specimen collection. Bacterial specimen collection is the process of collecting biological samples from a patient using aseptic procedures in order to detect, isolate, and identify the bacteria causing disease. It is used for various applications, such as diagnostics and research, by several end users, such as hospitals and clinics, diagnostic laboratories, academic and research institutions, and others.

What Is The Bacterial And Viral Specimen Collection Market Growth Forecast?

The bacterial and viral specimen collection market size is expected to see rapid growth in the next few years. It will grow to $44.98 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to growing demand for rapid diagnostic testing, expansion of decentralized healthcare services, increasing adoption of molecular diagnostics, rising focus on pandemic preparedness, growth in research on emerging pathogens. Major trends in the forecast period include increasing demand for sterile and standardized collection kits, rising adoption of transport media with extended stability, growing focus on infection control protocols, expansion of home-based and point-of-care collection solutions, enhanced emphasis on sample integrity and traceability.

Global Bacterial And Viral Specimen Collection Market Segmentation

1) By Product: Bacterial Specimen Collection, Viral Specimen Collection 2) By Application: Diagnostics, Research 3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End Users Subsegments: 1) By Bacterial Specimen Collection: Swabs, Transport Media, Culture Plates And Media, Blood Culture Bottles, Biopsy And Tissue Collection Kits, Urine Collection Containers, Other Specialized Collection Devices 2) By Viral Specimen Collection: Viral Transport Media, Blood Collection Tubes, Saliva Collection Kits, Sputum Collection Containers, Stool Collection Kits, Other Specialized Collection Devices

What Is The Driver Of The Bacterial And Viral Specimen Collection Market?

The rising prevalence of infectious diseases is expected to propel the growth of the bacterial and viral specimen collection market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from person to person either directly or indirectly. The rising prevalence of infectious diseases is primarily driven by increasing urbanization, which leads to higher population density and closer human contact, facilitating faster disease transmission and creating ideal conditions for pathogens to spread more easily among communities. Bacterial and viral specimen collection supports infectious disease management by providing essential samples that enable precise detection and diagnosis, facilitating timely and targeted medical intervention. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 cases, while the incidence rate grew from 2.5 to 2.9 per 100,000 persons, reflecting a significant upward trend over the year. Therefore, the rising prevalence of infectious diseases is driving the growth of the bacterial and viral specimen collection industry.

Key Players In The Global Bacterial And Viral Specimen Collection Market

Major companies operating in the bacterial and viral specimen collection market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group AG, Hologic Inc., bioMérieux SA, Quidel Corporation, QIAGEN N.V., DiaSorin S.p.A., Greiner Bio-One International GmbH, Spectrum Solutions LLC, Hardy Diagnostics Inc., EKF Diagnostics Holdings Plc, Trinity Biotech Plc, Puritan Medical Products Company LLC, Wuxi NEST Biotechnology Co. Ltd., Copan Diagnostics Inc., VIRCELL S.L., Medical Wire & Equipment Co. Ltd., HiMedia Laboratories Pvt. Ltd., Longhorn Vaccines and Diagnostics LLC, Beaver Biomedical Engineering Co. Ltd.

Global Bacterial And Viral Specimen Collection Market Trends and Insights

Major companies operating in the bacterial and viral specimen collection market are focusing on introducing innovative solutions, such as viral DNA and RNA extraction kits, to improve the efficiency, accuracy, and speed of pathogen detection and analysis. A viral DNA and RNA extraction kit is a laboratory tool used to isolate and purify viral genetic material from clinical samples for accurate molecular testing and diagnosis. For instance, in April 2024, New England Biolabs, a US-based life sciences company, launched the Monarch Mag Viral DNA and RNA Extraction Kit, a magnetic bead-based purification kit designed for rapid, reliable, and highly sensitive extraction of viral DNA and RNA from sample types such as saliva, respiratory swabs, and wastewater (with enrichment). It supports manual and automated workflows compatible with platforms such as KingFisher Flex and Agilent Bravo, enabling high-throughput processing. The kit enhances detection sensitivity for low viral loads, includes carrier RNA for improved recovery, and is suitable for downstream applications including qPCR, RT-qPCR, ddPCR, and next-generation sequencing (NGS). It aims to meet demands in infectious disease testing, viral genome sequencing, and environmental surveillance with scalable, hands-free workflows.

What Are Latest Mergers And Acquisitions In The Bacterial And Viral Specimen Collection Market?

In April 2024, Eurofins Scientific SE, a Luxembourg-based testing laboratory company, acquired Ascend Clinical LLC for an undisclosed amount. With this acquisition, Eurofins Scientific aims to reinforce its presence in renal and transplant testing in the United States, broaden its clinical client base, and elevate the standard of care for patients by integrating Ascend's expertise with Eurofins' extensive laboratory network, technological capabilities, and geographic reach. Ascend Clinical LLC is a US-based clinical laboratory company specializing in infectious disease testing, which includes bacterial and viral specimen collection and testing.

Regional Outlook

North America was the largest region in the bacterial and viral specimen collection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bacterial And Viral Specimen Collection Market?

The bacterial and viral specimen collection market consists of revenues earned by entities by providing services, such as microbiological sampling, blood sample collection, specimen transport, documentation and data management, and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bacterial And Viral Specimen Collection Market Report 2026?

The bacterial and viral specimen collection market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial and viral specimen collection industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.